Stock News

Abbvie (ABBV) Share Price Rose While Wedbush Securities Has Lowered Stake; Bank Amer (BAC) Shareholder Sather Financial Group Cut Position as Stock Declined

Sather Financial Group Inc decreased its stake in Bank Amer Corp (BAC) by 3.49% based on its latest 2017Q3 regulatory filing with the SEC. Sather Financial Group Inc sold 16,188 shares as the company’s stock declined 6.00% while stock markets rallied. The institutional investor held 448,281 shares of the major banks company at the end of 2017Q3, valued at $11.36M, down from 464,469 at the end of the previous reported quarter. Sather Financial Group Inc who had been investing in Bank Amer Corp for a number of months, seems to be less bullish one the $330.86B market cap company. The stock increased 0.76% or $0.24 during the last trading session, reaching $31.72. About 66.49M shares traded. Bank of America Corporation (NYSE:BAC) has risen 58.64% since January 21, 2017 and is uptrending. It has outperformed by 41.94% the S&P500.

Wedbush Securities Inc decreased its stake in Abbvie Inc (ABBV) by 4.92% based on its latest 2017Q3 regulatory filing with the SEC. Wedbush Securities Inc sold 3,838 shares as the company’s stock rose 6.17% with the market. The institutional investor held 74,173 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $6.59M, down from 78,011 at the end of the previous reported quarter. Wedbush Securities Inc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $167.05B market cap company. The stock increased 0.80% or $0.83 during the last trading session, reaching $104.64. About 4.99M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 21, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Sather Financial Group Inc, which manages about $361.65M and $365.11M US Long portfolio, upped its stake in Us Bancorp Del (NYSE:USB) by 7,011 shares to 110,288 shares, valued at $5.91M in 2017Q3, according to the filing. It also increased its holding in C H Robinson Worldwide Inc (NASDAQ:CHRW) by 6,025 shares in the quarter, for a total of 116,223 shares, and has risen its stake in Syntel Inc (NASDAQ:SYNT).

Among 32 analysts covering Bank of America (NYSE:BAC), 21 have Buy rating, 0 Sell and 11 Hold. Therefore 66% are positive. Bank of America had 105 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained Bank of America Corporation (NYSE:BAC) on Tuesday, July 18 with “Buy” rating. Citigroup maintained it with “Buy” rating and $17 target in Tuesday, July 19 report. The rating was maintained by RBC Capital Markets with “Buy” on Friday, October 6. JP Morgan maintained the stock with “Overweight” rating in Thursday, April 7 report. As per Tuesday, October 6, the company rating was maintained by Oppenheimer. The stock has “Underperform” rating by Macquarie Research on Tuesday, August 25. The rating was upgraded by Vetr to “Buy” on Monday, August 24. The rating was upgraded by Credit Agricole on Friday, January 29 to “Outperform”. Societe Generale downgraded the stock to “Hold” rating in Tuesday, September 13 report. The firm has “Hold” rating given on Tuesday, January 2 by Robert W. Baird.

Since August 10, 2017, it had 0 insider buys, and 1 insider sale for $2.10 million activity.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.08, from 1.12 in 2017Q2. It dropped, as 68 investors sold BAC shares while 569 reduced holdings. 117 funds opened positions while 547 raised stakes. 6.91 billion shares or 9.01% more from 6.34 billion shares in 2017Q2 were reported. 930,203 are held by Johnson Inv Counsel Inc. 3.80 million were reported by Oregon Public Employees Retirement Fund. 14.01M are owned by State Of Wisconsin Investment Board. Brighton Jones Ltd Limited Liability Company holds 61,611 shares. Rex Advsr Ltd Co stated it has 0.67% in Bank of America Corporation (NYSE:BAC). Folger Nolan Fleming Douglas Cap Management Incorporated reported 34,038 shares or 0.13% of all its holdings. Paloma Ptnrs Communications accumulated 0.22% or 622,189 shares. Forbes J M And Company Limited Liability Partnership accumulated 1.67% or 265,008 shares. Advisor Prtn Ltd Liability Company owns 203,882 shares. Natixis Asset Mngmt owns 69,226 shares for 0.15% of their portfolio. Sirios Cap Lp reported 2.52 million shares. Hartford Financial Mngmt invested 0.27% of its portfolio in Bank of America Corporation (NYSE:BAC). Kanawha Lc reported 0.04% in Bank of America Corporation (NYSE:BAC). 1.16M were reported by Bp Public Limited Liability Co. Accredited Invsts Incorporated holds 11,179 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 71 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Monday, June 26. Credit Suisse maintained the stock with “Hold” rating in Thursday, July 20 report. The stock has “Buy” rating by Goldman Sachs on Monday, March 7. As per Wednesday, April 6, the company rating was initiated by Societe Generale. UBS maintained the stock with “Buy” rating in Friday, October 23 report. Raymond James initiated the stock with “Outperform” rating in Friday, September 2 report. The firm has “Buy” rating by Jefferies given on Friday, July 14. The stock of AbbVie Inc. (NYSE:ABBV) earned “Neutral” rating by UBS on Friday, October 13. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Thursday, September 28 by Deutsche Bank. Leerink Swann initiated AbbVie Inc. (NYSE:ABBV) on Tuesday, October 18 with “Mkt Perform” rating.

Since July 31, 2017, it had 0 buys, and 8 insider sales for $45.57 million activity. 87,040 shares were sold by RICHMOND TIMOTHY J., worth $8.57M. Shares for $6.24 million were sold by GONZALEZ RICHARD A. $705,655 worth of AbbVie Inc. (NYSE:ABBV) was sold by SALEKI-GERHARDT AZITA. Schumacher Laura J sold 145,510 shares worth $14.07M. 6,699 shares were sold by Michael Robert A., worth $589,512.

Wedbush Securities Inc, which manages about $769.93 million US Long portfolio, upped its stake in Teva Pharmaceutical Inds (NYSE:TEVA) by 24,828 shares to 96,975 shares, valued at $1.71 million in 2017Q3, according to the filing. It also increased its holding in Gilead Sciences Inc (NASDAQ:GILD) by 10,259 shares in the quarter, for a total of 64,442 shares, and has risen its stake in Sector Consumer Staples (XLP).

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Zuckerman Gp Llc owns 75,628 shares or 1.65% of their US portfolio. Page Arthur B reported 7,315 shares. Legacy Prtn reported 59,024 shares stake. Pinnacle Fincl Prtnrs stated it has 113,039 shares or 1.29% of all its holdings. Hemenway Trust Limited Co stated it has 0.58% of its portfolio in AbbVie Inc. (NYSE:ABBV). Strategic Serv has 5,122 shares. Mcrae Capital Inc accumulated 4,092 shares. Moreover, Klingenstein Fields & Lc has 0.06% invested in AbbVie Inc. (NYSE:ABBV). Smith Moore & holds 28,731 shares or 0.73% of its portfolio. Mu Invs Limited reported 320 shares or 0.02% of all its holdings. Illinois-based Barrington Strategic Wealth Management Group Limited Company has invested 0.45% in AbbVie Inc. (NYSE:ABBV). The Colorado-based Alps has invested 0.34% in AbbVie Inc. (NYSE:ABBV). 15,175 are held by Autus Asset Ltd Liability Co. Etrade Cap Ltd Liability Corporation has 0.38% invested in AbbVie Inc. (NYSE:ABBV) for 118,939 shares. Illinois-based Advisory has invested 0.19% in AbbVie Inc. (NYSE:ABBV).

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 18.29 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *